17,273 followers
Features of patients with advanced EGFR-mutated non-small cell lung cancer benefiting from immune checkpoint inhibitors: Background Although immune checkpoint inhibitors (ICIs) generally show poor therapeutic efficacy in #immunology… https://t.co/LtDBgmK5